[go: up one dir, main page]

MX9301789A - Nuevos oligopeptidos lipofilicos con actividad inmunomoduladora. - Google Patents

Nuevos oligopeptidos lipofilicos con actividad inmunomoduladora.

Info

Publication number
MX9301789A
MX9301789A MX9301789A MX9301789A MX9301789A MX 9301789 A MX9301789 A MX 9301789A MX 9301789 A MX9301789 A MX 9301789A MX 9301789 A MX9301789 A MX 9301789A MX 9301789 A MX9301789 A MX 9301789A
Authority
MX
Mexico
Prior art keywords
oligopeptides
pct
immunomodulating
date oct
immunomodulating activity
Prior art date
Application number
MX9301789A
Other languages
English (en)
Inventor
Christopher Penney
Boulos Zacharie
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Publication of MX9301789A publication Critical patent/MX9301789A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/42—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se describen nuevos oligopéptidos inmunomoduladores pequeños y de estructura simple. Los oligopéptidos de la presente invención poseen una cadena de alquilo lipofílica larga.
MX9301789A 1992-04-03 1993-03-30 Nuevos oligopeptidos lipofilicos con actividad inmunomoduladora. MX9301789A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86269492A 1992-04-03 1992-04-03
US91746492A 1992-07-21 1992-07-21

Publications (1)

Publication Number Publication Date
MX9301789A true MX9301789A (es) 1993-10-01

Family

ID=27127715

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301789A MX9301789A (es) 1992-04-03 1993-03-30 Nuevos oligopeptidos lipofilicos con actividad inmunomoduladora.

Country Status (11)

Country Link
US (1) US5688771A (es)
EP (1) EP0635026B1 (es)
JP (1) JPH07505371A (es)
CN (1) CN1083073A (es)
AT (1) ATE186549T1 (es)
AU (1) AU662411B2 (es)
CA (1) CA2133569A1 (es)
DE (1) DE69327001D1 (es)
MX (1) MX9301789A (es)
NZ (1) NZ251297A (es)
WO (1) WO1993020100A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0741697B1 (en) * 1994-01-24 1999-09-15 Fujisawa Pharmaceutical Co., Ltd. Amino acid derivatives and their use as phospholipase a2 inhibitors
GB9419011D0 (en) * 1994-09-21 1994-11-09 Peptech Uk Ltd Use of muramyl peptide compounds
KR100464787B1 (ko) * 2002-03-20 2005-01-06 박용석 글루탐산염을 이용한 양전하 지질의 제조방법
CN100582085C (zh) 2002-10-10 2010-01-20 耶达研究及发展有限公司 脂肪醇的碱性酯及它们作为抗炎药或免疫调节剂的用途
US20050065114A1 (en) * 2003-09-23 2005-03-24 Jean-Claude Yvin Therapeutical treatment with oligo-beta- (1,3) -glucans, drugs used in said treatment
AU2006211510B8 (en) * 2005-02-02 2011-04-21 Teva Pharmaceutical Industries, Ltd. Process for producing polypeptide mixtures using hydrogenolysis
CA2578647A1 (en) * 2007-02-15 2008-08-15 University Of Saskatchewan Reducing post-operative adhesion formation with intraperitoneal glutamine
WO2009033763A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Nafarelin and carboxymethyl-phe-leu as therapeutic agents
US20100190711A1 (en) * 2007-09-11 2010-07-29 Dorian Bevec Big gastrin i as a therapeutic agent
JP5802553B2 (ja) * 2008-04-24 2015-10-28 セリミュネックス・ファーマシューティカルス・インコーポレイテッドＴｈｅｒｉｍｕｎｅＸ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． ペプチジルジアシルグリセリド
DE102009034779A1 (de) 2009-07-25 2011-02-03 Emc Microcollections Gmbh Synthetische Analoga bakterieller Lipopeptide und ihre Anwendung zur Therapie und Prophylaxe allergischer Erkrankungen
WO2011145083A2 (en) 2010-05-20 2011-11-24 Ecolab Usa Inc. Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof
EP2928871B1 (en) * 2012-12-07 2017-02-01 Council of Scientific & Industrial Research Histidinylated cationic amphiphiles, process for preparation thereof and their liposomal formulation
MX2022011751A (es) * 2020-03-26 2022-12-02 Nutrivert Llc Enantiómeros lipofílos de muramil dipéptido desacetilglucosamina con actividad antiinflamatoria y promotora del crecimiento.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965017D1 (en) * 1978-12-22 1983-04-14 Anvar New compounds associating peptidyl or aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds
US4258029A (en) * 1979-04-23 1981-03-24 Connaught Laboratories Limited Synthetic adjuvants for stimulation of antigenic responses
AU583578B2 (en) * 1984-12-14 1989-05-04 Australian Commercial Research & Development Limited Amino acid and peptide inhibitors of human leucocytic elastase
DE3736113A1 (de) * 1987-10-26 1989-05-03 Hoechst Ag Arzneimittel, darin enthaltene phosphorhaltige 2-isoxazoline und isoxazole, sowie herstellungsverfahren fuer diese heterocyclischen verbindungen
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
WO1990005141A1 (en) * 1988-11-10 1990-05-17 Australian Commercial Research & Development Limited Amino acid and peptide inhibitors of human leukocytic elastase and collagenase
SI9011830B (sl) * 1990-09-27 1999-12-31 Univerza V Ljubljani, Fakulteta Za Farmacijo Novi N-acildipeptidi, postopki za njihovo pripravo in farmacevtski pripravki, ki jih vsebujejo

Also Published As

Publication number Publication date
CA2133569A1 (en) 1993-10-14
EP0635026B1 (en) 1999-11-10
NZ251297A (en) 1996-11-26
CN1083073A (zh) 1994-03-02
ATE186549T1 (de) 1999-11-15
EP0635026A1 (en) 1995-01-25
JPH07505371A (ja) 1995-06-15
US5688771A (en) 1997-11-18
AU3900193A (en) 1993-11-08
DE69327001D1 (de) 1999-12-16
WO1993020100A1 (en) 1993-10-14
AU662411B2 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
MX9301789A (es) Nuevos oligopeptidos lipofilicos con actividad inmunomoduladora.
ES2082003T3 (es) Deshidrodidemnina b.
MX9101913A (es) Derivados de quinazolinas para potenciar la actividad antitumoral
ES2055193T3 (es) Nuevo epimero de 1 alfa-hidroxi-vitamina d2 y derivados.
ES2131208T3 (es) Composiciones de limpieza personal.
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
IS4057A (is) Efni til að auka kyngetu
EP0676954A4 (en) HIV LOCK VIRUS.
DE69115280D1 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
ES2118953T3 (es) Tratamiento de disfunciones mediante la inyeccion de microparticulas.
ATE114472T1 (de) System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.
DE59511002D1 (de) Wirkstoffe für die behandlung der senilen xerosis und zubereitungen
FR2687287B3 (fr) Piege pour l'extermination des insectes, et plus particulierement pour l'extermination des dipteres adultes.
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
MC1930A1 (fr) Produit antiviral
ATE116850T1 (de) Mittel zur behandlung von erkrankungen der venen und des analbereichs.
DE50003730D1 (de) Caspase 8-inhibitoren zur immunsuppression
EP0757697A4 (en) Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
FR2677223B1 (fr) Composition insecticide a base de rotenone, notamment pour le traitement des parasites humains et animaux.
DE68908445D1 (de) Mittel zur behandlung von lebererkrankungen.
DE58903550D1 (de) Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen.
IT1216096B (it) L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.
ES2181722T3 (es) Marcfortinas sustituidas en la posicion 14 y derivados utiles como agentes antiparasitarios.